 Vinblastine is a powerful anticancer drug derived from the Madagascar periwinkle plant. Traditionally, it was extracted using a laborious process that was expensive and inconsistent. To address this issue, researchers developed a new method using synthetic biology to create a yeast strain capable of producing Vinblastine directly from its precursor molecules. This yeast strain was then used to produce Vinblastine at higher levels than previously possible, making it more accessible and affordable. This article was authored by D. Gao, Ting Feilu, Jutsong Gao, and others.